Cn1c(=O)c2c(nc(N/N=C3/SCC(=O)N3Cc3ccccc3)n2C)n(C)c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?